MRONJ risk associated with combined antiresorptive and vascular endothelial growth factor receptor tyrosine kinase inhibitors
- DOI
- 10.1016/j.bonr.2026.101934
- Published
- 2026-09
- Container
- Bone Reports
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.bonr.2026.101934,
title = {MRONJ risk associated with combined antiresorptive and vascular endothelial growth factor receptor tyrosine kinase inhibitors},
author = {G. Mammone and R. Coropciuc and T. Van den Wyngaert and R. Jacobs and P. Bossier and C. Kerkhofs and L. Wijnen and S. Meerschaert and E. Vissenaekens and P.M. Clement and O. Bechter and P.R. Debruyne and A. Laenen and B. Beuselinck},
year = {2026},
journal = {Bone Reports},
doi = {10.1016/j.bonr.2026.101934},
url = {https://doi.org/10.1016/j.bonr.2026.101934}
}RIS
TY - JOUR TI - MRONJ risk associated with combined antiresorptive and vascular endothelial growth factor receptor tyrosine kinase inhibitors AU - G. Mammone AU - R. Coropciuc AU - T. Van den Wyngaert AU - R. Jacobs AU - P. Bossier AU - C. Kerkhofs AU - L. Wijnen AU - S. Meerschaert AU - E. Vissenaekens AU - P.M. Clement AU - O. Bechter AU - P.R. Debruyne AU - A. Laenen AU - B. Beuselinck PY - 2026 JO - Bone Reports DO - 10.1016/j.bonr.2026.101934 UR - https://doi.org/10.1016/j.bonr.2026.101934 ER -
APA
Mammone, G., Coropciuc, R., Wyngaert, T. V. D., Jacobs, R., Bossier, P., Kerkhofs, C., Wijnen, L., Meerschaert, S., Vissenaekens, E., Clement, P., Bechter, O., Debruyne, P., Laenen, A., & Beuselinck, B. (2026). MRONJ risk associated with combined antiresorptive and vascular endothelial growth factor receptor tyrosine kinase inhibitors. Bone Reports. https://doi.org/10.1016/j.bonr.2026.101934
Source records
- crossref · retrieved 2026-09-26T14:33:18.847Z